In Vivo Pharmacological Characterisation of Bilastine, a Potent and Selective Histamine H 1 Receptor Antagonist

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustín   Orjales Aurelio  

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist

By Ozaki S.   Kawamoto H.   Itoh Y.   Miyaji M.   Azuma T.   Ichikawa D.   Nambu H.   Iguchi T.   Iwasawa Y.   Ohta H.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

The Gerbil Elevated Plus-maze II - Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists

By Varty G.B.   Cohen-Williams M.E.   Morgan C.A.   Pylak U.   Duffy R.A.   Lachowicz J.E.   Carey G.J.   Coffin V.L.  

Neuropsychopharmacology, Vol. 27, Iss. 3, 2002-09 ,pp. : 371-379

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of T-0632, a novel potent and selective CCK A receptor antagonist, in vivo

By Taniguchi H.   Yazaki N.   Yomota E.   Shikano T.   Endo T.   Nagasaki M.  

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 227-233

Elsevier

Access to resources Recommend Favorite

Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK 1 receptor antagonist

By Cirillo R.   Astolfi M.   Conte B.   Lopez G.   Parlani M.   Terracciano R.   Fincham C.I.   Manzini S.  

European Journal of Pharmacology, Vol. 341, Iss. 2, 1998-01 ,pp. : 201-209

Elsevier

Access to resources Recommend Favorite